Concepedia

Jennifer Smotryski

JS

Statistics

Publications

4

Citations

126

H-Index

4

Active since

2010

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Jennifer Smotryski is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicine, and pharmacology.

Top concepts

Publications per year

2010–2011

4

Publications

4

Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia

Shu‐Wei Yang, Jennifer Smotryski, William T. McElroy et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

, , +7

The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia

Ginny D. Ho, Shu‐Wei Yang, Jennifer Smotryski et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 32 citations · Full text

, , +7

Pyrazoloquinolines as PDE10A inhibitors: Discovery of a tool compound

William T. McElroy, Zheng Tan, Kallol Basu et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 31 citations · Full text

, , +4

Structure–activity relationships of 2,4-diphenyl-1H-imidazole analogs as CB2 receptor agonists for the treatment of chronic pain

Shu‐Wei Yang, Jennifer Smotryski, Julius J. Matasi et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 11 citations · Full text

, , +13

1–4 of 4